2m 2m 2m 2m 2m 2m 2m
Helix Biomedix (HXBM)
OTC
$1.75+$0.60 (+52.17%)
Price as of Aug 14, 2026- N/AMarket Cap
- -56.25%1-Year Change
- BiotechnologyIndustry
Helix Biomedix (HXBM)
$1.75+$0.60 (+52.17%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$1.75
$1.75
$1.75
1-Year Range
$1.00
$3.50
$1.75
Latest Close$1.75
Change
+$0.60 (+34.29%)
Volume100
Information as of 08/14/2026
Company Profile
HELIX BIOMEDIX INC
https://www.helixbiomedix.comN/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Biotechnology
19125 Northcreek Parkway, Bothell, WA, United States, 98011
425 402 8400Helix BioMedix, Inc., a biotechnology company, develops peptide-based therapeutics for dermatology and skin health in the United States. It is developing HB4208 for treatment of the rare disease Xeroderma Pigmentosum; and BIOACTIVE SMARTPEPTIDES, a bioactive peptide ingredient for skin care companies. The company was founded in 1988 and is based in Bothell, Washington.
Key Executives
- Robin L. Carmichael
Current Ownership Distribution
- Other134,721 (59.95%)
- Insiders89,987 (40.05%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)